Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: Emphasis on Alzheimer's disease and Parkinson's disease

  • 118 Accesses

  • 69 Citations

Abstract

As neurodegenerative disorders are better characterized, the importance of genetic and environmental interactions is becoming more evident. Among the neurodegenerative disorders, Alzheimer's disease and Parkinson's disease are both characterized by large losses of nicotinic binding sites in brain. In addition, losses in nicotinic receptors occur during normal aging. Chronic administration of nicotine in man or experimental animals increases the number of nicotinic receptors in brain. Nicotine has been shown to possess some neuroprotective properties for both cholinergic and dopaminergic neurons. These neuroprotective properties, when better understood, may provide important information on normal aging and neurodegenerative disorder related neuronal cell death. Understanding the functional aspects of neuronal nicotinic receptor subtypes may lead to successful therapeutic treatments or disease preventative strategies for neurodegenerative disorders.

This is a preview of subscription content, log in to check access.

References

  1. Adem, A., Nordberg, A., Bucht, G., and Winblad, B. (1986). Nicotinic and muscarinic binding sites on lymphocytes from Alzheimer patients. In Fisher, A., Hanin, I., and Lachman, C. (eds.),Alzheimer's and Parkinson's Disease: Strategies for Research and Development, Plenum Press, New York, pp. 337–344.

  2. Aquilonius, S. (1989). Parkinson's disease-etiology and smoking.Prog. Brain Res. 79:329–333.

  3. Araujo, D. M., Lapchak, P. A., Collier, B., and Quirion, R. (1989). N-[3H]Methylcarbamylcholine binding sites in the rat and human brain: Relationship to functional nicotinic autoreceptors and alterations in Alzheimer's disease.Prog. Brain Res. 79:345–352.

  4. Arneric, S. P., Sullivan, J. P., and Williams, M. (1995). Neuronal nicotinic acetylcholine receptors-novel targets for CNS therapeutics. In Bloom, F. E., and Kupfer, D. J. (eds.),Psychopharmacology: The Fourth Generation of Progress, Raven Press, New York.

  5. Ashton, H., Marsh, V., Millman, J., Rawlins, M., Stepney, R., Telford, R., and Thompson, J. W. (1979). Patterns of behavioral, autonomic, and electrophysiological response to cigarette smoking and nicotine in man. In Remond, A., and Izard, C. (eds.),Electrophysiological Effects of Nicotine, Elsevier, New York.

  6. Aubert, I., Araujo, D. M., Cecyre, D., Robitaille, Y., Gauthier, S., and Quirion, R. (1992). Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases.J. Neurochem. 58:529–541.

  7. Barclay, L., and Kheyfets, S. (1988). Tobacco use in Alzheimer's disease.Alzheimer's Dis. Assoc. Disord. 2:172.

  8. Baron, J. A. (1986). Cigarette smoking and Parkinson's disease.Neurology 36:1490–1496.

  9. Baumann, R. J., Jameson, H. D., McKean, H. E., Haack, D. G., and Weisberg, L. M. (1980). Cigarette smoking and Parkinson disease: A comparison of cases with matched neighbors.Neurology 30:839–843.

  10. Benwell, M. E. M., Balfour, D. J. K., and Anderson, J. M. (1988). Evidence that tobacco smoking increases the density of (−)-[3H]nicotine binding sites in human brain.J. Neurochem. 50:1243–1247.

  11. Bertrand, D., Ballivet, M., and Rungger, D. (1990). Activation and blocking of neuronal nicotinic acetylcholine receptor reconstituted in xenopus oocytes.Proc. Natl. Acad. Sci. 87:1993–1997.

  12. Bertrand, D., Bertrand, S., and Ballivet, M. (1992). Pharmacological properties of the homomeric α7 receptor.Neurosci. Lett. 146:87–90.

  13. Bogdanovic, N., Nilsson, L., Adem, A., Winblad, B., and Bergström, L. (1993). Decrease of somatostatin receptor binding in the rat cerebral cortex after ibotenic acid lesion of the nucleus basalis magnocellularis: A quantitative autoradiographic study.Brain Res. 628:31–38.

  14. Brenner, D. E., Kukull, W. A., van Belle, G., Bowen, J. D., McCormick, W. C., Teri, L., and Larson, E. B. (1993). Relationship between cigarette smoking and Alzheimer's disease in a population-based case-control study.Neurology 43:293–300.

  15. Calne, D. B., McGeer, E., Eisen, A., and Spencer, P. (1986). Alzheimer's disease, Parkinson's disease, and motoneurone disease: Abiotropic interaction between aging and environment?Lancet Nov. 8:1067–1070.

  16. Carson, D. A., and Ribeiro, J. M. (1993). Apoptosis and disease.Lancet 341:1251–1254.

  17. Changeux, J., Girqudat, J., and Dennis, M. (1987). The nicotinic acetylcholine receptor: Molecular architecture of a ligand-regulated ion channel.TIPS 8:459–465.

  18. Chini, B., Tarroni, P., Rubboli, F., Raimondi, E., and Clementi, F. (1991), α3, β4, and α5 human nicotinic receptor subunits genes: Genetic linkage, chromosomal localization and differential expression in neuronal and nonneuronal cells.Biol. Psychiatry 2:809–812.

  19. Citron, M. T., Olterdorf, C., and Hass, S. (1992). Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increase β-protein production.Nature 360:672–674.

  20. Clark, R. F., and Goate, A. M. (1993). Molecular genetics of Alzheimer's disease.Arch. Neurol. 50:1164–1172.

  21. Collins, A. C., and Marks, M. J. (1989). Chronic nicotine exposure and brain nicotinic receptors-influence of genetic factors.Prog. Brain Res. 79:137–146.

  22. Collins, A. C., and Marks, M. J. (1991). Progress towards the development of animal models of smoking-related behaviors.J. Addict. Dis. 10:109–126.

  23. Collins, M. K. L., Perkins, G. R., Rodriguez-Tarduchy, G., Nieto, M. A., and Lopez-Rivas, A. (1993). Growth factors as survival factors: Regulation of apoptosis.Bioassays 16(2):133–138.

  24. Copeland, J. R., Adem, A., Jacob, P., III, and Nordberg, A. (1991). A comparison of the binding of nicotine and nornicotine stereoisomers to nicotine binding sites in rat brain cortex.Naunyn-Schmiedeberg's Arch. Pharmacol. 343:123–127.

  25. Deneris, E. S., Connolly, J., Rogers, S. W., and Duvoisin, R. (1991). Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptors.TIPS 12:34–40.

  26. Dies, R., and Reznikoff, M. (1969). Personality and smoking patterns in a twin population.J. Proj. Tech. Pers. Assess. 33:457–463.

  27. Dunnett, S. B., Whishaw, I. Q., Jones, G. H., and Bunch, S. T. (1987). Behavioural, biochemical and histochemical effects of different neurotoxic amino acids injected into nucleus basalis magnocellularis of rats.Neuroscience 20(2):653–669.

  28. Falkeborn, Y., Larsson, C., Nordberg, A., and Slanina, P. (1983). A comparison of the regional ontogenesis of nicotine-and muscarine-like binding sites in mouse brain. Internat.J. Dev. Neurosci. 1:289–296.

  29. Fisher, R. A. (1958). Cancer and smoking.Nature 182:596.

  30. Flynn, D. D., and Marsh, D. C. (1986). Characterization of L-(3H-nicotine) binding in human cerebral cortex; Comparison between Alzheimer's disease and the normal.J. Neurochem. 47:1948–1954.

  31. Fratiglioni, L. (1993). Epidemiology of Alzheimer's disease: Issues of etiology and validity.Acta Neurol. Scand. (Suppl. 145)87:1–70.

  32. Friedland R. P. (1994). Epidemiology and neurobiology of the multiple determinants of Alzheimer's disease.Neurobiol. Aging 15(2):239–241.

  33. Fuxe, K., Andersson, K., Eneroth, P., Jansson, A., von Euler, G., Tinner, B., Bjelke, B., and Agnati, L. F. (1989). Neurochemical mechanisms underlying the neuroendocrine actions of nicotine: Focus on the plasticity of central cholinergic nicotinic receptors.Prog. Brain. Res. 79:197–207.

  34. Fuxe, K., Janson, A. M., Jansson, A., Andersson, K., Eneroth, P., and Agnati, L. F. (1990). Chronic nicotine treatment increases dopamine levels and reduces dopamine utilization in substantia nigra and in surviving forebrain dopamine nerve terminal systems after a partial di-mesencephalic hemitransection.Naunyn-Schmiedeberg's Arch. Pharmacol. 341:171–181.

  35. Giorguieff, M. F., le Floc'h, M. L., Glowinski, J., and Besson, M. J. (1977). Involvement of cholinergic presynaptic receptors of nicotinic and muscarinic types in the control of the spontaneous release of dopamine from striatal dopaminergic terminals in the rat.J. Pharmacol. Exp. Ther. 200:535–544.

  36. Goate, A., Chartier-Harlin, M. C., and Mullan, M. (1991). Segregation of a missense mutation in the amyloid precursor protein gene with familiar Alzheimer's disease.Nature 349:704–706.

  37. Golbe, L. I., Cody, R. A., and Duvoisin, R. C. (1986). Smoking and Parkinson's disease, search for a dose-response relationship.Arch. Neurol. 43:774–778.

  38. Goldman, D., Deneris, E., Luyten, W., Kochhar, A., Patrick, J., and Heinemann, S. (1987). Members of a nicotinic acetylcholine receptor gene family are expressed in different regions of the mammalian central nervous system.Cell 48:965–973.

  39. Grady, S. R., Marks, J. J., and Collins, A. C. (1994). Desensitization of nicotine-stimulated [3H]dopamine release from mouse striatal synaptosomes.J. Neurochem. 62:1390–1398.

  40. Graves, A. B., van Duijn, C. M., Chandra, V., Fratiglioni, L., Heyman, A., Jorn, A. F., Kokmen, E., Kondo, K., Mortimer, J. A., Rocca, W. A., Shalat, S. L., Soininen, H., and Hofman, A. (1991). Alcohol and tobacco consumption as risk factors for Alzheimer's disease: A collaborative re-analysis of case-control studies.Int. J. Epidemiol. 20(2)(Suppl. 2):48–57.

  41. Greenamyre, J. T., and Young, A. B. (1989). Excitatory amino acids and Alzheimer's disease.Neurobiol. Aging 10:593–602.

  42. Grenhoff, J., Janson, A. M., Svensson, T. H., and Fuxe, K. (1991). Chronic continuous nicotine treatment causes decreased burst firing of nigral dopamine neurons in rats partially hemitransected at the meso-diencephalic junction.Brain Res. 562:347–351.

  43. Grunberg, N. E., Winders, S. E., and Wevers, M. E. (1991). Gender differences in tobacco use.Health Psychol. 10:143–153.

  44. Haack, D. G., Baumann, R. J., McKean, H. E., Jameson, H. D., and Turbek, J. A. (1981). Nicotine exposure and Parkinson disease.Am. J. Epidemiol. 114(2):191–200.

  45. Hanauer, S. B. (1994). Nicotine for colitis-The smoke has not yet cleared.N. Engl. J. Med. 330(12):856–857.

  46. Hardy, J. A., et al. (1985). Transmitter deficits in Alzheimer's disease.Neurochem. Int. 7:545–563.

  47. Härfstrand, A., Adem, A., Fuxe, K., Agnati, L., Andersson, K., and Nordberg, A. (1988). Distribution of nicotinic cholinergic receptors in the rat telencephalon and diencephalon: A quantitative receptor autoradiographical study using3H-nicotine.Acta Physiol. Scand. 132:1–14.

  48. Heckers, S., Ohtake, T., Wiley, R. G., Lappi, D. A., Geula, C., and Mesulam, M. M. (1994). Complete and selective cholinergic denervation of rat neocortex and hippocampus but not amygdala by an immunotoxin against the p75 NGF receptor.J. Neurosci. 14(3):1271–1289.

  49. Heishman, S. J., Snyder, F. R., and Henningfield, J. E. (1993). Performance, subjective, and physiological effects of nicotine in non-smokers.Drug Alcohol Depend. 34:11–18.

  50. Hindmarch, I., Kerr, J. S., and Sherwood, N. (1990). Effects of nicotine gum on psychomotor performance in smokers and non-smokers.Psychopharmacology 100:535–541.

  51. Hofman, A., Schulte, W., Tanja, T. A., van Duijn, C. M. Haaxma, R., Lameris, A. J., Otten, V. M., and Saan, R. J. (1989). History of dementia and Parkinson's disease in 1st-degree relatives of patients with Alzheimer's disease.Neurology 39:1589–1592.

  52. James, J. R., Villanueva, H. F., Johnson, J. H., Arezo, S., and Rosecrans, J. A. (1994). Evidence that nicotine can acutely desensitize central nicotinic acetylcholinergic receptors.Psychopharmacology 114(3):456–462.

  53. Janson, A. M., and Moller, A. (1993). Chronic nicotine treatment counteracts nigral cell loss induced by a partial mesodiencephalic hemitransection: An analysis of the total number and mean volume of neurons and glia in substantia nigra of the male rat.Neurosci. 57:931–941.

  54. Janson, A. M., Fuxe, K., Kitayama, I., Härfstrand, A., and Agnati, L. F. (1988). Morphometric studies on the protective action of nicotine on the substantia nigra dopamine nerve cells after partial hemitransection in the male rat.Neurosci. Lett. Suppl. 26:S.88.

  55. Janson, A. M., Fuxe, K., Agnati, L. F., Jansson, A., Bjelke, B., Sunström, E., Andersson, K., Härfstrand, A., Goldstein, M., and Owman, C. (1989). Protective effects of chronic nicotine treatment on lesioned nigrostriatal dopamine neurons in the male rat.Prog. Brain Res. 79:257–265.

  56. Jarvik, M. E. (1991). Beneficial effects of nicotine.Br. J. Addict. 86:571–575.

  57. Jick, H., and Walker, A. M. (1983). Cigarette smoking and ulcerative colitis.N. Engl. J. Med. 308(5):261–263.

  58. Jones, R. A. (1986). Individual differences in nicotine sensitivity.Addict. Behav. 11:435–438.

  59. Katz, B., and Thesleff, S. (1957). A study of the “desensitization” produced by acetylcholine at the motor end-plate.J. Physiol. 138:63–80.

  60. Kessler, I. I., and Diamond, E. L. (1971). Epidemiologic studies of Parkinson's disease I. Smoking and Parkinson's disease: A survey and explanation hypothesis.Am. J. Epidemiol. 94(1):16–25.

  61. Kinney, H. C., O'Donnell, T. J., Kriger, P., and White, W. F. (1993). Early developmental changes in [3H]nicotine binding in the human brainstem.J. Neurosci. 55(4):1127–1138.

  62. Larsson, C., Nordberg, A., Falkeborn, Y., and Lundberg, P. Å. (1985). Regional [3H]acetylcholine and [3H]nicotine binding in developing mouse brain. Internat.J. Dev. Neurosci. 3:667–671.

  63. Larsson, C., Nilsson, L., Halen, A., and Nordberg, A. (1987). Subchronic treatment of rats with nicotine: Effects on tolerance and on [3H]acetylcholine and [3H]nicotine binding in the brain.Drug Alcohol Depend. 17:37–45.

  64. Loo, D. T., Copani, A., Pike, C. J., Whittemore, E. R., Walencewicz, A. J., and Cotman, C. W. (1993). Apoptosis is induced by β-amyloid in cultured central nervous system neurons.Proc. Natl. Acad. Sci. USA 90:7951–7955.

  65. Lopez-Garcia, J. C., Fernandez-Ruiz, J., Escobar, M. L., Bermudez-Rattoni, F., and Tapia, R. (1993). Effects of excitotoxic lesions of the nucleus basalis magnocellularis on conditioned taste aversion and inhibitory avoidance in the rat.Pharmacol. Biochem. Behav. 45:147–152.

  66. Luetje, C. W., and Patrick, J. (1991). Both α-and β-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors.J. Neurosci. 11(3):837–845.

  67. Luetje, C. W., Patrick, J., and Seguela, P. (1990). Nicotine receptors in the mammalian brain.FASEB J. 4:2753–2760.

  68. Marks, M. J., Romm, E., Gaffney, D. K., and Collins, A. C. (1986a). Nicotine-induced tolerance and receptor changes in four mouse strains.J. Pharmacol. Exp. Ther. 237(3):809–819.

  69. Marks, M. J., Stitzel, J. A., and Collins, A. C. (1986b). Doseresponse analysis of nicotine tolerance and receptor changes in two inbred mouse strains.J. Pharmacol. Exp. Ther. 239(2):358–364.

  70. Marttila, R. J., and Rinne, U. K. (1980). Smoking and Parkinson's disease.Acta Neurol. Scand. 62:322–325.

  71. Mayeux, R., Tang, M., Marder, K., Cote, L. J., and Stern, Y. (1994). Smoking and Parkinson's disease.Move. Disord. 9(2):207–212.

  72. Miner, L. L., Marks, M. J., and Collins, A. C. (1984). Classical genetic analysis of nicotine-induced seizures and nicotinic receptors.J. Pharmacol. Exp. Ther. 231(3):545–554.

  73. Mullan, M., Crawford F., and Axelman, K. (1992). A new mutation in APP demonstrates that the pathogenic mutations for probable Alzheimer's disease from the β-amyloid sequence.Nature Genet. 1:345–347.

  74. Neary, D., Snowden, J. S., Mann, D. M. A., Bowen, D. M., Sims, N. R., Northen, B., Yates, P. O., and Davison, A. N. (1986). Alzheimer's disease: A correlative study.J. Neurol. Neurosurg. Psychiat. 49:229–237.

  75. Nee, L. E., Eldridge, R., and Sunderlant, T. (1987). Dementia of the Alzheimer type: Clinical and family study of 22 twin pairs.Neurology 37:359–363.

  76. Nefzger, M. D., Quadfasel, F. A., and Darl, V. C. (1968). A retrospective study of smoking in Parkinson's disease.Am. J. Epidemiol. 88:149–158.

  77. Newhouse, P. A., and Hughes, J. R. (1991). The role of nicotine and nicotinic mechanisms in neuropsychiatric disease.Br. J. Addict. 86:521–526.

  78. Nordberg, A. (1992). Neuroreceptor changes in Alzheimer's disease.Cerbovasc. Brain Metab. Rev. 4:303–328.

  79. Nordberg, A. (1993). Neuronal nicotinic receptors and their implications in aging and neurodegenerative disorders in mammals.J. Reprod. Fert. Suppl. 46:145–154.

  80. Nordberg, A., and Winblad, B. (1986a). Brain nicotinic and muscarinic receptors in normal aging and dementia. In Fisher, A., and Hanin, I. (eds.), Alzheimer's and Parkinson's disease-Strategies for research and development.Advances in Behavioural Biology, Plenum Press, New York, Vol. 29, pp. 95–108.

  81. Nordberg, A., and Winblad, B. (1986b). Reduced number of3H-nicotine and3H-acetylcholine binding sites in the frontal cortex of Alzheimer brains.Neurosci. Lett. 72:115–119.

  82. Nordberg, A., Wahlström, G., Arnelo, U., and Larsson, C. (1985). Effect of long-term nicotine treatment on [3H]-nicotine binding sites in the rats brain.Drug Alcohol Depend. 16:9–17.

  83. Nordberg, A., Adem, A., Nilsson, L., Romanelli, L., and Zhang, X. (1988). Heterogeneous cholinergic nicotinic receptors in the CNS. In Clementi, F., Botti, C., and Sher, E. (eds.),Nicotinic Acetylcholine Receptors in the Nervous System, NATO series H, Springer-Verlag, New York, pp. 331–350.

  84. Nordberg, A., Fuxe, K., Holmstedt, B., and Sundwall, A. (1989a). Nicotinic receptors in the CNS-their role in synaptic transmission.Prog. Brain Res. 79:1–366.

  85. Nordberg, A., Nilsson-Håkansson, L., Adem, A., Hardy, J., Alafuzoff, I., Lai, Z., Herrera-Marschitz, M., and Winblad, B. (1989b). The role of nicotinic receptors in the pathophysiology of Alzheimer's disease.Prog. Brain Res 79:353–362.

  86. Nordberg, A., Hartvig, P., Lilja, A., Viitanen, M., Amberla, K., Lundqvist, H., Andersson, Y., Ulin, J., Winblad, B., and Långström, B. (1990). Decreased uptake and binding of11C-nicotine in brain of Alzheimer patients as visualized by positron emission tomography.J. Neural Trans. 2:215–224.

  87. Nordberg, A., Zhang, X., Fredriksson, A., and Eriksson, P. (1991). Neonatal nicotine exposure induces permanent changes in brain nicotinic receptors and behaviour in adult mice.Dev. Brain Res. 63:201–207.

  88. Nordberg, A., Alafuzoff, I., and Winblad, B. (1992). Nicotinic and muscarinic subtypes in the human brain: Changes with aging and dementia.J. Neurosci. Res. 31:103–111.

  89. Nordberg, A., Lija, A., Lundqvist, H., Hartvig, P., Amberla, K., Viitanen, M., Warpman, U., Johansson, M., Hellström-Lindahl, E., Bjurling, P., Fasth, K. J., Långström, B., and Winblad, B. (1992). Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by positron emission tomography.Neurobiol. Aging 13:747–758.

  90. Nordberg, A., Lundqvist, H., Hartvig, P., Lilja, A., and Långström, B. (1995). Kinetic analysis of regional (S)(−)11C-nicotine binding in normal and Alzheimer brains in vivo assessment using positron emission tomography.Alzheimer Dis. Assoc. Disord. (in press).

  91. Nybäck, H., Nordberg, A., Långström, B., Halldin, C., Hartvig, P., Åhlin, A., Swahn, C.-G., and Sedvall, G. (1989). Attempts to visualize nicotinic receptors in brain of monkey and man by positron emission tomography.Prog. Brain Res. 79:313–319.

  92. Ochoa, E. L. M., Chattopadbyay, A., and McNamee, M. G. (1989). Desensitization of the acetylcholine receptor: Molecular mechanisms and effect of modulators.Cell. Mol. Neurobiol. 9:141–177.

  93. Owman, C., Fuxe, K., Janson, A. M., and Kåhrström, J. (1989). Studies of protective actions of nicotine on neuronal and vascular functions in the brain of rats: Comparison between sympathetic noradrenergic and mesostriatal dopaminergic fiber systems, and the effect of a dopamine agonist.Prog. Brain Res. 79:267–276.

  94. Page, K. J., Everitt, B. J., Robbins T. W., Marston, H. M., and Wilkinson, L. S. (1991). Dissociable effects on spatial maze and passive avoidance acquisition and retention following ampa-and ibotenic acid-induced excitotoxin lesions of the basal forebrain in rats: Differential dependence on cholinergic neuronal loss.Neuroscience 43(2/3):457–472.

  95. Parazzini, F., Vecchia, C. L., Bocciolone, L., and Franceschi, S. (1991). The epidemiology of endometrial cancer.Gynecol. Oncol. 41:1–16.

  96. Pedersen, N. (1981). Twin similarity for usage of common drugs.Twin Research 3: Epidemiological and Clinical Studies. Alan R. Liss, New York, pp. 53–59.

  97. Perkins, K. A., Grobe, J. E., Fonte, C., and Breus, M. (1992). “Paradoxical” effects of smoking on subjective stress vs. cardiovascular arousal in males and females.Pharmacol. Biochem. Behav. 42:301–311.

  98. Perkins, K. A., Epstein, L. H., Brobe, J., and Fonte, C. (1994). Tobacco abstinence, smoking cues, and the reinforcing value of smoking.Pharmacol. Biochem. Behav. 47:107–112.

  99. Perry, E. K., Pery, R., Smith, C. J., Dick, D. J., Candy, J. M., Edwardson, J. A., Fairbairn, A., and Blessed, G. (1987). Nicotinic abnormalities in Alzheimer's and Parkinson's diseases.J. Neurosurg. Psychiatry 50:806–809.

  100. Prasad, C., Ikegami, H., Shimizu, I., and Onaivi, E. S. (1994). Chronic nicotine intake decelerates aging of nigrostriatal dopaminergic neurons.Life Sci. 54(16):1169–1184.

  101. Prince, M., Cullen, M., and Mann, A. (1994). Risk factors for Alzheimer's disease and dementia: A case-control study based on the MRC elderly hypertension trial.Neurology 44:97–104.

  102. Raaschou-Nielsen, E. (1960). Smoking habits in twins.Danish Med. Bull. 7(3):82–88.

  103. Raimondi, E., Rubboli, F., Moralli, D., Chinin, B., Fornasari, D., Tarroni, P., DeCarli, L., and Clementi, F. (1991). Chromosomal localization and physical linkage of the gene encoding the human 3, 5 and β4 neuronal nicotinic receptor subunits.Genomics 12:849–850.

  104. Rajput, A. H., Offord, K. P., Beard, M., and Kurland, L. T. (1987). A case-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease.Neurology 37:226–232.

  105. Riggs, J. E. (1992). Cigarette smoking and Parkinson's disease: The illusion of a neuroprotective effect.Clin. Neuropharmacol. 15(2):88–99.

  106. Romanelli, L., Öhman, B., Adem, A., and Nordberg, A. (1988). Subchronic treatment of rat with nicotine: Interconversion of nicotine receptor subtypes in brain.Eur. J. Pharmacol. 148:289–291.

  107. Sahakian, B. J., and Coull, J. T. (1994). Nicotine and tetrahydroaminoacradine-Evidence for improved attention in patients with dementia of the Alzheimer type.Drug Dev. Res. 31(1):80–88.

  108. Schröder, H., Biacobini, E., Struble, R. G., Luiten, P. G. M., Van der Zee, E. A., Zilles, K., and Strosberg, A. D. (1991). Muscarinic cholinoreceptive neurons in the frontal cortex in Alzheimer's disease.Brain Res. Bull. 27:631–636.

  109. Schulz, D. W., Kuchel, G. A., and Zigmond, R. E. (1989). Neuronal bungarotoxin blocks the nicotinic stimulation of endogenous dopamine release from rat striatum.Neurosci. Lett. 98:310–316.

  110. Schulz, D. W., Kuchel, G. A., and Zigmond, R. E. (1993). Decline in response to nicotine in aged rat striatum: Correlation with a decrease in a subpopulation of nicotinic receptors.J. Neurochem. 61:2225–2232.

  111. Slotkin, T. A., Orband-Miller, L., and Queen, K. L. (1987). Development of [3H]nicotine binding sites in brain.J. Pharmacol. Exp. Ther. 233:361–368.

  112. Smolen, A., and Marks, M. J. (1991). Genetic selections for nicotine and cocaine sensitivity in mice.J. Addict. Dis. 10:7–28.

  113. Spencer, P. S., Nunn P. B., Hugon, J., Ludolph, A. C., Ross, S. M., Roy, D. N., and Robertson, R. C. (1987). Guam amyotrophic lateral sclerosis-Parkinsonism-dementia linked to a plant excitant neurotoxin.Science 237:517–522.

  114. Sugaya, K., Giacobini, E., and Chiappinelli, V. A. (1990). Nicotinic acetylcholine receptor subtypes in human frontal cortex: Changes in Alzheimer's disease.J. Neurosci. Res. 27:349–359.

  115. Sumikawa, K., and Miledi, R. (1989). Change in desensitization of cat muscle acetylcholine receptor caused by coexpression of Torpedo acetylcholine receptor subunits in Xenopus oocytes.Proc. Natl. Acad. Sci. USA 86(1):367–371.

  116. Treves, T. A., Chandra, V., and Korczyn, A. D. (1993a). Parkinson's and Alzheimer's diseases: Epidemiological Comparison.Neuroepidemiology 12:336–344.

  117. Treves, T. A., Chandra, V., and Korczyn, A. D. (1993b). Parkinson's and Alzheimer's diseases: Epidemiological comparison.Neuroepidemiology 12:345–349.

  118. van Duijn, C. M., and Hofman, A. (1991). Relation betwen nicotine intake and Alzheimer's disease.Br. Med. J. 302:1491–1494.

  119. van Duijn, C. M., and Hofman, A. (1992). Risk factors for Alzheimer's disease: The EURODEM collaborative reanalysis of case-control studies.Neuroepidemiology 11(Suppl 1):106–113.

  120. Vaux, D. L., Haecker, G., and Strasser, A. (1994). An evolutionary perspective on apoptosis.Cell 76:777–779.

  121. Villanueva, H. F., Arezo, S., and Rosecrans, J. A. (1992). Preliminary studies on the in vivo desensitization of central nicotinic receptors by (−)-nicotine. InEffects of Nicotine on Biological Systems, Advances in Pharmacological Sciences, Birkhäuser Verlag, Basel, pp. 355–359.

  122. Wagster, M. V., Whitehouse, P. J., Walker, L. C., Kellar, K. J., and Price, D. L. (1990). Laminar organization and agerelated loss of cholinergic receptors in temporal neocortex of rhesus monkey.J. Neurosci. 10:2879–2885.

  123. Ward, C. D., Duvoisin, R. C., Ince, S. E., Nutt, J. D., Eldridge, R., and Calne, D. B. (1983). Parkinson's disease in 65 pairs of twins and in a set of quadruplets.Neurology 33: 815–824.

  124. Wevers, A., Jeske, A., Lobron C. H., Birsch, C. H., Heinemann, S., Maelicke, S., Schröder, R. and Schröder, H. (1994). Cellular distribution of nicotinic acetylcholine receptor subunit mRNAs in the human cerebral cortex as revealed by non-isotopic in situ hybridization.Mol. Brain Res. 25:122–128.

  125. Whitehouse, P. J., Martino, A. M., Autuono, P. G., Lowenstein, P. R., Coyle, J. T., Price, D. L., and Kellar, K. J. (1986). Nicotinic acetylcholine binding sites in Alzheimer's brain.Brain Res. 371:146–151.

  126. Whitehouse, P. J., Martino, A. M., Wagster, M. V., Price, D. L., Mayeux, R., Attack, J. R., and Kellar, K. J. (1988). Reduction in3H-nicotinic acetylcholine binding in Alzheimer's and Parkinson's disease: An autoradiographical study.Neurology 38:720–723.

  127. Wonnacott, S., Russell, M. A. H., and Stolerman, I. P. (1990).Nicotine Psychopharmacology-Molecular, Cellular and Behavioural Aspects, Oxford University Press, Oxford.

  128. Wright, S. C., Zhong, J., Zheng, H., and Larrick, J. W. (1993). Nicotine inhibition of apoptosis suggests a role in tumor promotion.FASEB J. 7:1045–1051.

  129. Zaimis, E., and Heads, S. (1976). In Zaimis, E. (ed.),Handbook of Experimental Pharmacology, Neuromuscular Junction, Vol. 42, Springer, Berlin, pp. 365–419.

  130. Zhang, X., Wahlström, G., and Nordberg, A. (1990). Influence of development and aging in nicotinic receptor subtypes in rodent brain.Int. J. Dev. Neurosci. 8:715–721.

  131. Zhang, X., Gong, Z-H., and Nordberg, A. (1994). Effects of chronic treatment with (+) and (−) nicotine on nicotinic acetylcholine receptors and N-methyl-D-aspartate receptors in rat brain.Brain Res. 644:32–39.

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

James, J.R., Nordberg, A. Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: Emphasis on Alzheimer's disease and Parkinson's disease. Behav Genet 25, 149–159 (1995). https://doi.org/10.1007/BF02196924

Download citation

Key Words

  • Nicotinic receptors
  • Alzheimer's disease
  • Parkinson's disease
  • genetics
  • environmental
  • neuroprotective